Arca
Skip to content
Tools
Tools

Materialise Personalized Guides and Models for Craniomaxillofacial Surgery CMF Titanium Guides and 1 more

Cranial Surgical Planning And Instrument Guides. 510(k) K253308, from Materialise NV (Leuven, BE). Product code PPT, class 2.

As of Nov 18, 2026, K253308 is an FDA 510(k) held by Materialise NV, substantially equivalent on Jan 7, 2026 after 100 days, with no recalls tied to it in FDA's recall database.

  • Review time: 100 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

CMF Titanium Guides CMF Titanium Guides are intended to guide the marking of bone and/or guide surgical instruments in craniofacial surgery. CMF Titanium Guides are used during bone repositioning/reconstruction surgical operations for orthognathic and reconstruction (including bone harvesting) indications. CMF Titanium Guides are intended for children, adolescents and adults.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Record

Type
Special
Received
Sep 29, 2025
Review panel
Neurology
Regulation
21 CFR 882.4310

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.